Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2001

View Archived Issues

Study suggests topiramate may be useful in nicotine addiction

3M and GSK collaborate to formulate novel respiratory drugs

Interim results show OrCel's efficacy and speed in healing diabetic ulcers

NPS Pharmaceuticals continues progress during Q3 2001

New clinical studies support effectiveness of Eros Therapy in female sexual dysfunction

Blockade of mglu5 receptors reduces L-DOPA-induced dyskinesia

New HDL-elevating agent characterized by AtheroGenics at American Heart Association meeting

Antisense approach to preventing intimal hyperplasia post-PTCA examined in pig model

Survival of transplanted dopamine neurons significantly increased using CEP-1347

Fiscal Q2 at AnorMED marked by progress in clinical development programs

Catalytic antioxidant AEOL-10150 protects mice from ischemic brain damage

Peptide memory enhancer progresses through preclinical development

Orally active p38 MAP kinase effectively inhibits progression of collagen-induced arthritis

Phase II clinical results for 5G1.1 anticomplement antibody support further testing in RA

DPC-333, a selective, orally active TACE inhibitor with potential in inflammation

Uriach describes potent and selective COX-2 inhibitors

Novel 5-HT2C receptor antagonists and uses of these compounds patented by Fujisawa

Taisho discloses new series for renal and cerebrovascular disorders

Pyridyl-thiazolyl compounds for PDE4-mediated conditions

Orally available triterpenes for liver diseases

Merck receives patent coverage for new GnRH antagonists

FR-900482 analogues with antitumor activity under study in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...